Global Transcriptome Sequencing Market Growth (Status and Outlook) 2025-2031

The global Transcriptome Sequencing market size is predicted to grow from US$ 2682 million in 2025 to US$ 6108 million in 2031; it is expected to grow at a CAGR of 14.7% from 2025 to 2031.

Transcriptome sequencing employs high-throughput sequencing technologies to get access to almost all transcripts of specific tissues or cells in a certain state by comprehensive and rapid cDNA sequencing, becoming the basis as well as the starting point for the research of gene expression. The main objectives of transcriptome research include the classification of all transcriptional products, the determination of the transcription structure of genes (such as starting sites, 5′ and 3′ terminals, splicing patterns, and post-transcriptional modifications), and the changes in the expression levels of individual transcripts during development. This technology has been widely used in biological research, medical and clinical research, and drug development.

The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The cost of RNA-Seq has decreased significantly over the past decade, making it more accessible to researchers and clinicians. This cost reduction is driven by advancements in sequencing technologies and economies of scale. Transcriptome sequencing is playing a critical role in identifying patient-specific biomarkers and therapeutic targets. The growing focus on precision medicine is driving adoption in oncology, rare diseases, and pharmacogenomics. Increased funding for genomics and transcriptomics research from governments, non-profits, and private investors is supporting market growth. Initiatives like the Cancer Genome Atlas (TCGA) and Human Cell Atlas (HCA) are driving large-scale transcriptome studies.

LPI (LP Information)' newest research report, the “Transcriptome Sequencing Industry Forecast” looks at past sales and reviews total world Transcriptome Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Transcriptome Sequencing sales for 2025 through 2031. With Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcriptome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcriptome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcriptome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcriptome Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Coding RNA
Noncoding RNA

Segmentation by Application:
Biomedical Field
Non-medical Field

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Eurofins Scientific
Roche
Bio-Rad
Agilent Technologies
LabCorp
QIAGEN
Pacific Biosciences
Azenta
BGI Genomics
Novogene
Macrogen
Shanghai ZJ Bio-Tech
Tsingke Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.